Huateng Pharma Develops Caronic Anhydride & Derivatives As Paxlovid Intermediates
Hunan Province, China, 2022-Mar-29 — /EPR Network/ — On February 16, 2022, the data on Paxlovid previously published by Pfizer and submitted to the FDA [read full press release…]